Bevacizumab resistance in breast cancer: are neuropilins the key?

被引：1
|
作者：
Staton, C. A. [1 ]
Yang, Z. [1 ]
Reed, M. W. R. [1 ]
Brown, N. J. [1 ]
机构：
[1] Univ Sheffield, Sch Med & Biomed Sci, Sect Oncol, Acad Surg Oncol Unit,Microcirculat Res Grp, Sheffield S10 2TN, S Yorkshire, England
来源：
BREAST CANCER RESEARCH | 2008年 / 10卷 / Suppl 2期
关键词：
Breast Cancer; Vascular Endothelial Growth Factor; Bevacizumab; Tubule Formation; Vascular Endothelial Growth Factor Receptor;
D O I：
10.1186/bcr1959
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [41] Present and future roles of bevacizumab in breast cancer
    Cortes-Funes, H.
    BREAST CANCER RESEARCH, 2007, 9 (01)
  • [42] Bevacizumab in Breast Cancer: The Best Is Yet to Come?
    Puhalla, Shannon
    Brufsky, Adam
    ONCOLOGY-NEW YORK, 2009, 23 (04): : 332 - 335
  • [43] Present and future roles of bevacizumab in breast cancer
    H Cortés-Funes
    Breast Cancer Research, 9
  • [44] Revisiting the Role of Bevacizumab in the Treatment of Breast Cancer
    Varella, Leticia
    Abraham, Jame
    Kruse, Megan
    SEMINARS IN ONCOLOGY, 2017, 44 (04) : 273 - 285
  • [45] Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
    Bear, Harry D.
    Tang, Gong
    Rastogi, Priya
    Geyer, Charles E., Jr.
    Robidoux, Andre
    Atkins, James N.
    Baez-Diaz, Luis
    Brufsky, Adam M.
    Mehta, Rita S.
    Fehrenbacher, Louis
    Young, James A.
    Senecal, Francis M.
    Gaur, Rakesh
    Margolese, Richard G.
    Adams, Paul T.
    Gross, Howard M.
    Costantino, Joseph P.
    Swain, Sandra M.
    Mamounas, Eleftherios P.
    Wolmark, Norman
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 310 - 320
  • [46] Review of bevacizumab in the treatment of metastatic breast cancer
    Heinemann, Volker
    EJC SUPPLEMENTS, 2008, 6 (04): : 13 - 18
  • [47] Trials of bevacizumab in breast cancer - a safety review
    Kumler, Iben
    Nielsen, Dorte Lisbet
    EXPERT OPINION ON DRUG SAFETY, 2012, 11 : S37 - S48
  • [48] Safety of Bevacizumab in Patients with Metastatic Breast Cancer
    Hamilton, Erika P.
    Blackwell, Kimberly L.
    ONCOLOGY, 2011, 80 (5-6) : 314 - 325
  • [49] Paclitaxel plus bevacizumab for metastatic breast cancer
    Haines, Ian E.
    Miklos, George L. Gabor
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (15): : 1637 - 1637
  • [50] A systematic review of bevacizumab efficacy in breast cancer
    Kumler, Iben
    Christiansen, Ole Grummedal
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2014, 40 (08) : 960 - 979
12345